Plenary Session |
Sunday, 1 June |
12:00 - 18:00 |
Registration |
18:00 |
ORG-1 : Welcome and Introduction
Bob Snyder, ICCS Program Chair |
18:15 |
Opening Session - Keynote Address, CSA Trust Mike Lynch Award
K-1 : Challenges/opportunities for chemical structure databases in the 21st century
Alexander J. Lawson, Elsevier Information Systems, Frankfurt
Presentation (2.5 MB) |
19:00 |
Welcoming Reception – Atrium, courtesy of CCDC |
20:00 |
Rijsttafel Dinner – Atrium, courtesy of Chemical Abstracts Service (CAS) |
Monday, 2 June |
08:30 - 10:30 |
Informatics for Bridging Between Chemistry and Biology
Kimito Funatsu, Presiding |
08:30 - 09:00 |
A-1 : Protein target prediction of toxic molecules identifies toxicological relationships Between proteins
Florian Nigsch, University of Cambridge |
09:00 - 09:30 |
A-2 : Exploiting systems chemical biology to predict and understand (un)desired drug effects
Josef Scheiber, Novartis Institutes for Biomedical Research
Presentation (2.4 MB) |
09:30 - 10:00 |
A-3 : Binding site similarity analysis for the functional classification of the protein kinase family
Richard M. Jackson, University of Leeds |
10:00 - 10:30 |
A-4 : Merging high-content screening and in silico approaches for compound profiling and mode-of-action analysis
Andreas Bender, Leiden / Amsterdam Center for Drug Research |
10:30 - 11:00 |
Break |
11:00 - 15:00 |
Cheminformatics
Lothar Terfloth, Presiding |
11:00 - 11:30 |
B-1 : Performance of common similarity measures in virtual screening and lead-hopping
J Christian Baber, Wyeth Research |
11:30 - 12:00 |
B-2 : Maximum unbiased validation (MUV) of ligand based virtual screening
Knut Baumann, University of Technology Braunschweig |
12:00 - 12:30 |
B-3 : Molecular similarity by pattern recognition: Fast calculation of 3D pharmacophore resemblence
Gerhard Wolber, Inte:Ligand GmbH |
12:30 - 13:30 |
Lunch |
13:30 - 14:00 |
B-4 : Analysis of natural products: Lessons from nature inspiring the design of new drugs
Peter Ertl, Novartis Institutes for BioMedical Research |
14:00 - 14:30 |
B-5 : It's all in the bits: Improved database searching with better bits
Harold Helson, CambridgeSoft Inc.
Presentation (0.4 MB) |
14:30 - 15:00 |
B-6 : Is there a general model for bioactivity?
Tudor I. Oprea, University of New Mexico
Presentation (0.9 MB) |
15:00 - 15:30 |
Break |
15:00 - 19:30 |
Exhibition & Posters |
15:30 - 17:30 |
Poster Presentations ( odd-numbered poster authors present) |
18:30 - 19:30 |
Reception |
19:30 - 21:30 |
Dinner |
Tuesday, 3 June |
08:30 - 15:00 |
Structure-Based Drug Design and Virtual Screening
Val Gillet, Presiding |
08:30 - 09:00 |
C-1 : SAMPL: Statistical assessment of the modeling of proteins and ligands
A. Geoffrey Skillman, OpenEye Scientific Software |
09:00 - 09:30 |
C-2 : HYDE: An integrated description of dehydration and H-bonding within protein ligand interfaces
Gudrun Lange, Bayer CropScience
Presentation (1.5 MB) |
09:30 - 10:00 |
C-3 : Specificity scoring
Joannis Apostolakis, LMU Munich / MoDeST |
10:00 - 10:30 |
C-4 : Flexophore, a new versatile 3D pharmacophore descriptor
Modest von Korff, Actelion Ltd. |
10:30 - 11:00 |
Break |
11:00 - 11:30 |
C-5 : A fragment-based computational protocol at PDB scale - Application to lead-optimization of DFG-out kinase inhibitors
Thomas Henry, MEDIT
Presentation (0.9 MB) |
11:30 - 12:00 |
C-6 : Can 3D ligand based virtual screening compete with docking? Application of molecular fields to virtual screening with the DUD dataset
Mark Mackey, Cresset BioMolecular Discovery Limited
Presentation (0.7 MB) |
12:00 - 12:30 |
C-7 : Novel fragment-like PTR1 inhibitors discovered by virtual screening
Chido Mpamhanga, Dundee University (Drug Dicovery Unit) |
12:30 - 12:45 |
Group Photo |
12:30 - 13:30 |
Lunch |
13:30 - 14:00 |
C-8 : Fleksy: a flexible approach to induced fit docking
Sander B. Nabuurs, Radboud University Nijmegen |
14:00 - 14:30 |
C-9 : Index-driven structure-based virtual screening
Jochen Schlosser, Center for Bioinformatics Hamburg (ZBH) |
14:30 - 15:00 |
C-10 : Algorithmic design of ligand binding pockets on protein surfaces
Susanne Eyrisch, Center for Bioinformatics, Saarland University |
15:00 - 15:30 |
Break |
15:00 - 19:30 |
Exhibition & Posters |
15:30 - 17:30 |
Poster Presentations (even-numbered poster authors present) |
18:30 - 19:30 |
Reception |
19:30 - 21:30 |
Dinner |
Wednesday, 4 June |
08:30 - 10:30 |
Virtual Chemistry
Markus Wagener, Presiding |
08:30 - 09:00 |
D-1 : De novo drug design using multi-objective evolutionary graphs
Christos Nicolaou, University of Cyprus
Presentation (0.6 MB) |
09:00 - 09:30 |
D-2 : Planning organic synthesis using reaction types derived from reaction databases
Christof H. Schwab, Molecular Networks GmbH
Presentation (0.6 MB) |
09:30 - 10:00 |
D-3 : Knowledge-based de novo design using reaction vectors
Hina Patel, University of Sheffield
Presentation (0.5 MB) |
10:00 - 10:30 |
D-4 : Recore: Instant 3D scaffold hopping using replacement fragments
Peter Richard Oledzki, BioSolveIT
Presentation (2.5 MB) |
10:30 - 11:00 |
Break |
11:00 - 13:00 |
Analysis of Large Data Sets
Christoph Steinbeck, Presiding |
11:00 - 11:30 |
E-1 : Turns revisited: Clustering turn structures using ESOMs leads to a uniform classification for open, normal and reverse turn families
Oliver Koch, The Cambridge Crystallographic Data Centre
Presentation (4.0 MB) |
11:30 - 12:00 |
E-2 : Searching fragment spaces with feature trees
Uta Lessel, Boehringer Ingelheim Pharma GmbH & Co. KG
Presentation (0.3 MB) |
12:00 - 12:30 |
E-3 : Three way comparison of chemical spaces avoiding structure exchange
Jens Loesel, Pfizer
Presentation (0.4 MB) |
12:30 - 13:00 |
E-4 : Use of data mining to help identify compounds that are unstable in DMSO
Jameed Hussain, GlaxoSmithKline
Presentation (0.4 MB)
|
13:00 - 13:00 |
Box Lunch |
13:00 - 23:00 |
Excursion to Amsterdam, dinner courtesy of Chemical Computing Group (CCG) |
Thursday, 5 June |
07:30 - 08:30 |
Hotel Check-out |
08:30 - 13:00 |
Structure-Activity and Structure-Property Prediction
Matthias Rarey, Presiding |
08:30 - 09:00 |
F-1 : CypScore - in silico case studies on metabolic stability optimization
Andreas H. Göller, Bayer Healthcare AG
Presentation (0.9 MB) |
09:00 - 09:30 |
F-2 : SyGMa: combining 2 knowledge and empirical scoring in the prediction of metabolites
Lars Ridder, Organon, a part of Schering-Plough Corporation
Presentation (0.6 MB) |
09:30 - 10:00 |
F-3 : TopoHERG – A highly selective pharmacophoric classifier for hERG-channel active compounds
Britta Nisius, Bayer Healthcare AG
Presentation (0.5 MB)
|
10:00 - 10:30 |
F-4 : Compound set optimization and sequential screening using emerging chemical patterns
Jens Auer, Bonn-Aachen International Center for Information Technology |
10:30 - 11:00 |
Break and Hotel Check-out |
11:00 - 11:30 |
F-5 : Interpretable Activity Models: exploring the limits of pharmacophore and 3D QSAR methods
David Anthony Evans, Eli Lilly |
11:30 - 12:00 |
F-6 : QSAR modeller seeks meaningful relationship
Craig L. Bruce, University of Nottingham
Presentation (1.7 MB)
|
12:00 - 12:30 |
F-7 : Rational design of M1-Muscarinic Antagonists using combinatorial transformation
Michael B. Bolger, Simulations Plus, Inc.
Presentation (1.2 MB)
|
12:30 - 13:00 |
F-8 : Structure-activity landscapes: a new way to study a structure-activity relationship
John H van Drie, John H Van Drie Research LLC |
13:00 - 13:15 |
Closing Remarks
Markus Wagener, ICCS Vice Chair |
13:15 - 14:00 |
Lunch or Box Lunch |
13:30 - 14:00 |
Shuttle buses leave for Schiphol Airport |
14:30 - 15:00 |
Shuttle buses leave for Schiphol Airport |
|
BioSolveIT Workshop |
14:00 - 17:00 |
Interactive Workshop on Virtual Screening and De Novo Design by BioSolveIT GmbH (registration with BioSolveIT required) |
17:00 - 17:30 |
Shuttle bus leaves for Schiphol Airport |
|
Poster Session |
P-1 : Discovery Portal - a novel tool to increase productivity, efficiency and transparency across R&D organizations
Jaroslaw Tomczak, Accelrys |
P-2 : A simple language for conversing between diverse applications
Omara Williams, Accelrys |
P-3 : The use of stereo descriptors in the context of a structure validation workflow
Omara Williams, Accelrys
Presentation (1.0 MB) |
P-4 : OSIRIS, an entirely in-house developed drug discovery informatics system
Thomas L Sander, Actelion Pharmaceuticals Ltd.
Presentation (1.9 MB) |
P-5 : Scientific database application without borders: Empowering the scientists
Man-Ling Lee, Aestel Scientific Information, LLC
Presentation (0.9 MB) |
P-6 : Diversity oriented virtual compound selection strategy for high throughput screening of potential anticancer agents
Gyorgy Dorman, AMRI |
P-7 : Investigating false predictions in mutagenicity QSAR models: What are we missing?
Catrin Hasselgren, AstraZeneca |
P-8 : Selecting druglike pieces for the jigsaw puzzle: towards optimal fragment spaces
Christof Gerlach, Bayer Schering Pharma |
P-9 : Going on SARfari in the protein kinase data jungle
Judith Günther, Bayer Schering Pharma |
P-10 : A probabilistic approach to classifying metabolic stability
Antonius ter Laak, Bayer Schering Pharma
Presentation (0.4 MB) |
P-11 : MCS clustering - A hierarchical clustering approach for large data sets
Alexander Böcker, Boehringer Ingelheim |
P-12 : Comparison of different approaches for cytochrome P450 modeling
Paul Czodrowski, Boehringer Ingelheim |
P-13 : Mapping of activity class characteristic substructures extracted from random fragment populations
Eugen Lounkine, Bonn-Aachen International Center for Information Technology
Presentation (0.5 MB) |
P-14 : In silico prediction of efflux substrates classification
Litai Zhang, Bristol Myers Squibb |
P-15 : Digging deep for GOLD - Using buriedness to improve discrimination between actives and inactives in docking
Noel M. O'Boyle, Cambridge Crystallographic Data Centre
Presentation (0.3 MB) |
P-16 : Representation, searching and enumeration of generic structures – From molecules towards patents
Szabolcs Csepregi, ChemAxon Ltd. |
P-17 : Hierarchical clustering of chemical structures by learned scaffolds
Miklos Vargyas, ChemAxon Ltd.
Presentation (0.9 MB) |
P-18 : Molecular framework based analysis of large chemical spaces
Anthony Joseph Trippe, Chemical Abstracts Service
Presentation (0.8 MB)
|
P-19 : Towards automated searching of data in Internet chemical databases
Xiaoxia Li, Chinese Academy of Sciences |
P-20 : Chemotype bias in virtual screening: the elephant in the room
Mark Mackey, Cresset BioMolecular Discovery Limited
Presentation (2.5 MB) |
P-21 : Rapid property profiling and similarity calculations in large virtual libraries
John Mordaunt Barnard, Digital Chemistry Ltd |
P-22 : Opportunities for integrating Markush patent searching with drug discovery
John Mordaunt Barnard, Digital Chemistry Ltd |
P-23 : A mathematically more precise taxonomy and nomenclature for polymers
Seymour Benjamin Elk, Elk Technical Associates |
P-24 : Indirect drug design using MD for flexible structure alignment application to HIV-1 protease inhibitors
Alok Juneja, Freie Universität |
P-25 : Optimizing drug classification by feature selection: To bind or not to bind that is the question
Ernst-Walter Knapp, Freie Universität |
P-26 : Understanding selective CDK4 inhibition through molecular dynamics
Nahren Manuel Mascarenhas, Indian Institute of Chemical Biology |
P-27 : Extracting chemical CYP proteins interactions from literature using natural language processing methods
Dazhi Jiao, Indiana University |
P-28 : An infrastructure for data mining public chemical & biological information
David J Wild, Indiana University
Presentation (1.5 MB)
|
P-29 : Binding affinity prediction of distinct inhibitors of group-1 and group-2 Neuraminidases (NAs): ArgusLab4/AScore protocol
Marija L. Mihajlovic, Institute for Multidisciplinary Research |
P-30 : Prediction of novel drug targets in the metazoan parasite schistosoma mansoni
Frank Oellien, Intervet Innovation GmbH |
P-31 : Performance of different machine learning methods
Uwe Koch, IRBM Merck Research Laboratories |
P-32 : Assessing and exploiting non-additivity in a structure-activity relationship
John H van Drie, John H Van Drie Research LLC |
P-33 : CLiDE Pro: A chemical OCR tool
Aniko Tunde Valko, Keymodule Ltd. |
P-34 : Molecular subgraph mining for analyzing ligand activity classes
Julio E. Peironcely, LACDR |
P-35 : Frequent Substructure Mining of GPCR ligands
Eelke van der Horst, Leiden University |
P-36 : Characterization of the inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors and proteochemometric models which are able to predict compound activity against particular target mutants
Gerard Jacob Pieter van Westen, Leiden University |
P-37 : Consensus modeling of chemical biodegradation pathways
ML Patel, Lhasa Limited
Presentation (0.4 MB)
|
P-38 : Scaffold hunter: Exploiting holes in chemical space
Stefan Wetzel, Max-Planck Institute for Molecular Physiology |
P-39 : Dynamic web application for drug design research
Mitchell Scott Chapman, Mesa Analytics & Computing
Presentation (1.7 MB)
|
P-40 : Parallel tiered clustering for large data sets using a modified Taylor’s algorithm
John David MacCuish, Mesa Analytics & Computing
Presentation (1.2 MB) |
P-41 : Ligand-based models for the isoform specificity of Cytochrome P450 substrates
Lothar Terfloth, Molecular Networks GmbH |
P-42 : Metabolomics approach for determining growth-specific metabolites based on Fourier transform ion cyclotron resonance mass spectrometry
Hiroki Takahashi, Nara Institute of Science and Technology |
P-43 : Clustering peptidases emplying structural features of their inhibitors
Mariusz Milik, Novartis Institutes for Biomedical Research
Presentation (0.4 MB) |
P-44 : Prediction of cell permeability
Paul Selzer, Novartis Institutes for Biomedical Research
Presentation (0.3 MB) |
P-45 : Validation using the RCSB: Good idea or bad idea?
Paul Charles Hawkins, OpenEye Scientific
Presentation (0.3 MB)
|
P-46 : Automated generation of fragment-based rules for mutagenicity prediction
Olaf Günter Othersen, Radboud University Nijmegen
Presentation (0.9 MB) |
P-47 : The detection of new active site conformations using molecular dynamics and rotamer assignments
Gijs Schaftenaar, Radboud University Nijmegen |
P-48 : Automated extraction of kinase hinge-binding fragments from the protein data bank
Dave John Wood, Radboud University Nijmegen |
P-49 : Get the best from substructure mining
Jeroen Kazius, Research For Charity Foundation |
P-50 : The RSC's Project Prospect: identification and reuse of chemistry in publications
Richard Kidd, Royal Society of Chemistry |
P-51 : In silico studies on P63 as a new drug-target protein
Anna Karawajczyk, RUMC |
P-52 : QSAR modelling of antineoplastic activities using NIH Roadmap Data
Alexey Zakharov, Russian Academy of Medical Science |
P-53 : GUSAR: new approach for multiple QSAR
Alexey Zakharov, Russian Academy of Medical Science |
P-54 : Fast empirical estimates of quantum mechanical descriptors for QSAR/QSPR modeling
Robert Fraczkiewicz, Simulations Plus, Inc.
Presentation (4.0 MB) |
P-55 : The representation, registration, and retrieval of substances with incompletely defined chemical structures
Keith T Taylor, Symyx Technologies Inc |
P-56 : Exploring synthetically accessible chemical space
Keith T Taylor, Symyx Technologies Inc |
P-57 : Development and visualization of the drug-likeness model
Masamoto Arakawa, The University of Tokyo
Presentation (0.7 MB) |
P-58 : Reverse analysis and multi-objective optimization of predictive models for polymer properties
Shun Goto, The University of Tokyo
Presentation (0.1 MB) |
P-59 : Development of a new regression analysis method using independent component analysis
Hiromasa Kaneko, The University of Tokyo
Presentation (0.1 MB) |
P-60 : Rule Induction of the site of metabolism by human Cytochromes P450 by data-mining
Michio Koyama, The University of Tokyo |
P-61 : Dynamic interplay between chemotype, similarity and docking studies: Towards a virtual screening approach for protein kinase B inhibitors
Jose L. Medina-Franco, Torrey Pines Institute for Molecular Studies
Presentation (9.1 MB) |
P-62 : Multi-fusion similarity maps for comparing the chemical space of compound databases
Jose L. Medina-Franco, Torrey Pines Institute for Molecular Studies
Presentation (0.7 MB) |
P-63 : The effect of structural redundancy on virtual screen performance
Robert D. Clark, Tripos International
Presentation (0.4 MB) |
P-64 : Topomer CoMFA for rapid optimization
Bernd Wendt, Tripos International
Presentation (0.8 MB)
|
P-65 : Development of an a priori ionic liquid design tool: Integration of a novel COSMO-RS molecular descriptor on neural networks
Jose Palomar, Universidad Autónoma de Madrid |
P-66 : Radial scan of the electrostatic potential of RNA double helices: An application on tRNA acceptor stems
Ray Marcel Marín, Universidad Nacional de Colombia |
P-67 : A graph theoretical approach to compare molecular electrostatic potentials
Ray Marcel Marín, Universidad Nacional de Colombia |
P-68 : Engineering polymer informatics
Nico Adams, University of Cambridge |
P-69 : Information extraction from the polymer literature
Lezan Hawizy, University of Cambridge
Presentation (0.9 MB) |
P-70 : MeFc and large chemical data sets
Hamse Y. Mussa, University of Cambridge |
P-71 : Kernel based least squares and large data sets
Hamse Y. Mussa, University of Cambridge |
P-72 : Molecular spam: Use of a modified spam filter for classification of bioactive molecules and drug target prediction
Florian Nigsch, University of Cambridge |
P-73 : SPECTRa-T: Machine-based data extraction and semantic searching of chemistry e-theses
Joseph Andrew Townsend, University of Cambridge |
P-74 : Creating chemo- & bioinformatics workflows: Further developments within the CDK-Taverna project
Thomas Kuhn, University of Cologne |
P-75 : Protein-Protein interactions as targets for drugs: A view from the binding site
Richard M. Jackson, University of Leeds |
P-76 : Determinants for selectivity in map kinase inhibitors by computational simulations
Nikita Basant, University of Modena and Reggio Emilia |
P-77 : Fragment weighting schemes for similarity-based virtual screening: Use of occurrence weighting
Shereen Arif, University of Sheffield |
P-78 : Effect of data standardization on the clustering of chemical structures
Chia-Wei Chu, University of Sheffield |
P-79 : Multiobjective optimisation of pharmacophore hypotheses: Bias towards low-energy conformations
Val Gillet, University of Sheffield |
P-80 : Weighted data fusion with turbo similarity searching to improve chemical similarity searching
John Holliday, University of Sheffield
Presentation (0.2 MB)
|
P-81 : Using wavelets to represent GRID fields in virtual screening
Richard Martin, University of Sheffield |
P-82 : A multiobjective approach to scoring functions for docking
Iain Peter Mott, University of Sheffield |
P-83 : Neighbourhood behaviour studies for lead optimisation
Georgios Papadatos, University of Sheffield
Presentation (0.5 MB) |
P-84 : Maximum unbiased validation (MUV) datasets for virtual screening by PubChem based chemogenomics data mining
Sebastian Georgios Rohrer, University of Technology Braunschweig
Presentation (1.6 MB)
|
P-85 : 3D-Visualization of molecular conformations in the MOGADOC database
Jürgen Vogt, University of Ulm |
P-86 : Similarity based correction for the predictions of compounds physicochemical properties
Andrius Sazonovas, Vilnius University
Presentation (0.7 MB) |
P-87 : Prediction of ionization constants for complex multicenter electrolytes utilizing proprietary ‘in house’ data
Andrius Sazonovas, Vilnius University
Presentation (0.7 MB) |
P-88 : A novel chemical database for sustainable development of synthesis routes - An instance of developing synthesis routes of quinolone derivatives
Kenzi Hori, Yamaguchi University |
P-89 : Combinatrial chemistry using theoretical calculations: An application to boric acid catalyzed esterification of phenol
Maki Shimeno, Yamaguchi University |
P-90 : Calculation of difference of free energy of solvations using the QM/MC/FEP method in chemical reactions
Keita Uezu, Yamaguchi University |
P-91 : Toward in silico screening using transition state data base for developing new synthesis routes
Toru Yamaguchi, Yamaguchi University |
P-92 : Tautomer generation. pKa based dominance conditions for generating the dominant tautomers
Ferenc Csizmadia, ChemAxon Ltd.
Presentation (0.8 MB) |
P-93 : Chemical terms – A language for cheminformatics
Akos Papp, ChemAxon
Presentation (1.1 MB) |